Search Results - "Solayman, Mohamed H."

Effect of plasma MicroRNA on antihypertensive response to beta blockers in the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) studies by Solayman, Mohamed H., Langaee, Taimour Y., Gong, Yan, Shahin, Mohamed H., Turner, Stephen T., Chapman, Arlene B., Gums, John G., Boerwinkle, Eric, Beitelshees, Amber L., El-Hamamsy, Manal, El-Wakeel, Lamia, Cooper-DeHoff, Rhonda M., Badary, Osama A., Johnson, Julie A.

“…β-blockers show variable efficacy as antihypertensives. Herein, we evaluated plasma miRNAs as biomarkers for defining antihypertensive response to β-blockers…”
Get full text

Effect of Genetic and Nongenetic Factors on the Clinical Response to Mineralocorticoid Receptor Antagonist Therapy in Egyptians with Heart Failure by Sarhan, Neven M., Shahin, Mohamed H., El Rouby, Nihal M., El‐Wakeel, Lamia M., Solayman, Mohamed H., Langaee, Taimour, Khorshid, Hazem, Schaalan, Mona F., Sabri, Nagwa A., Cavallari, Larisa H.

“…This prospective cohort study evaluated the association between the renin angiotensin aldosterone system genotypes and response to spironolactone in 155…”
Get full text

The impact of metformin use on the outcomes of relapse-remitting multiple sclerosis patients receiving interferon beta 1a: an exploratory prospective phase II open-label randomized controlled trial by Abdelgaied, Mohamed Y., Rashad, Mohamed Hamed, El-Tayebi, Hend M., Solayman, Mohamed H.

“…Background Multiple sclerosis (MS) is a chronic demyelinating neurodegenerative disorder. Elevated levels of pro-inflammatory mediators and some oxidative…”
Get full text

Correction to: The impact of metformin use on the outcomes of relapse‑remitting multiple sclerosis patients receiving interferon beta 1a: an exploratory prospective phase II open‑label randomized controlled trial by Abdelgaied, Mohamed Y., Rashad, Mohamed Hamed, El‑Tayebi, Hend M., Solayman, Mohamed H.

Get full text

Effect of Clinical and Genetic Factors on the Development of Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting (CABG) in Egyptian Patients Receiving Beta-Blockers by El Gindy, Dina M. K., Solayman, Mohamed H., Khorshid, Ramy, Schaalan, Mona F., El Wakeel, Lamia M.

“…Purpose Prophylactic beta-blockers are recommended to prevent postoperative atrial fibrillation (POAF) after coronary artery bypass grafting (CABG)…”
Get full text

Evaluation of the Safety Profile of Direct-Acting Antivirals on Patients with Hepatitis C Virus: A Pharmacovigilance Study by El-Marakby, Mai G, Solayman, Mohamed H, Sabri, Nagwa A

“…Hepatitis C virus (HCV) is the primary contributor to chronic hepatic diseases. A rapid change in the situation took place with the advent of oral…”
Get more information

Cross-Validation of High-Resolution Melting Analysis-Based Genotyping Platform by Langaee, Taimour, Stauffer, Lynda, Galloway, Cheryl, Solayman, Mohamed H, Cavallari, Larisa

“…Developing genetic and pharmacogenetic panels enhances genetic testing in clinical molecular diagnostics and precision medicine. This study was designed to…”
Get more information